In NSW, expert clinical guidance and cannabis medicine prescribing advice for general practitioners, community pharmacists and rural health practitioners is available via the John Hunter Hospital Pharmacy Department. 

The service can assist with:
  • understanding the latest evidence around cannabis medicines
  • understanding the regulatory requirements for cannabis prescription
  • considering tools to monitor a patient’s progress whilst using cannabis medicines
  • provision of protocols to facilitate cannabis medicine prescribing
The John Hunter Hospital Pharmacy Department can be contacted by email via HNELHD-JHHPharmacy@health.nsw.gov.au.

Public health practitioners working in metropolitan local health districts should consult their local medicines information services for clinical guidance and prescribing advice.

Clinical guidelines

A Therapeutic Goods Administration (TGA) review of the current clinical evidence for cannabis medicines in paediatric and adult epilepsies, multiple sclerosis, nausea and vomiting resulting from chemotherapy and HIV/AIDS therapy, pain, and palliative care is available on the TGA website.
 

Prescribing guidance

The Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE), based at the University of Newcastle, received funding from the NSW Government to develop practical NSW Cannabis Medicines Prescribing Guidance to provide interim information to support NSW medical practitioners in prescribing cannabis medicines to patients for conditions where cannabinoids are perceived to have some benefit.
 
Prescribing Guidance documents have been developed and are available on ACRE’s website.

​
Current as at: Monday 25 July 2022
Contact page owner: Pharmaceutical Services